Skip to main content
SpringerLink
Log in

The Role of Noradrenaline, Vasopressin, and Terlipressin in Septic Shock

  • Chapter
Practical Issues Updates in Anesthesia and Intensive Care

  • 1923 Accesses

Abstract

Septic shock is still one of the most feared complications both in critically ill medical and surgical patients in the ICU: as a matter of fact, mortality still ranges between 30 and 60 %. In this chapter the use of pressors, in particular of noradrenalin and terlipressin, is reviewed: in case of suboptimal response to fluids and NE, an early use of low dose terlipressin has to be considered to widen the available therapeutic options. The use of hydrocortisone continuous infusion as combination therapy and of methylene blue in very difficult cases has also been addressed.

Prof. Biagio Allaria, former Director of the Critical Patient Department of the National Institute for the Study and Treatment of Tumors, Milan. Currently consultant in Clinical Risk Management at the same Institute.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Russel JA, Keith RW, Walley MD et al (2008) Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 358:877–887

    Article  Google Scholar 

  2. Vincent JL (2010) We should abandon randomized controlled trials in the intensive care unit. Crit Care Med 38(Suppl):S534–S538

    Article  PubMed  Google Scholar 

  3. Vincent JL, Zhang H, Szabo C, Preiser JC (2000) Effects of nitric oxide in septic shock. Am J Respir Crit Care Med 161:1781–1785

    Article  CAS  PubMed  Google Scholar 

  4. Bernard GR, Wheeler AP, Russell JA et al (1997) The effects of ibuprofen on the physiology and survival of patients with sepsis. N Engl J Med 336:912–918

    Article  CAS  PubMed  Google Scholar 

  5. Pocher P, Beckman JS, Liandet L et al (2007) Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87:315–324

    Article  Google Scholar 

  6. Salvemini D, Wang ZQ, Zweier J et al (1999) A unpeptidic mimic of superoxyde dismutase with therapeutic activity in rats. Science 286:304–306

    Article  CAS  PubMed  Google Scholar 

  7. Morelli A, Lange M, Estmer C et al (2007) Glibenclamide dose response in patients with septic shock; effects on norepinephrine requirements, cardiopulmonary performance and global oxygen transport. Shock 28:530–535

    CAS  PubMed  Google Scholar 

  8. De Baker D, Biston P, Devriendt J et al (2010) Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 362:779–789

    Article  Google Scholar 

  9. Hamazoni O, Georger JF, Monnet X et al (2010) Early administration of norepinephrine increased cardiac preload and cardiac output in septic patients with life-threatening hypotension. Crit Care 14:R142

    Article  Google Scholar 

  10. Monnet X, Jabot J, Maizel J et al (2011) Norepinephrine increases cardiac preload and reduces preload dependency assessed by passive leg raising in septic shock patients. Crit Care Med 39:689–694

    Article  CAS  PubMed  Google Scholar 

  11. Nouira S, Eldrons S, Dimassi S et al (2005) Effects of norepinephrine on static and dynamic preload indicators in experimental hemorrhagic shock. Crit Care Med 35:2339–2343

    Article  Google Scholar 

  12. Lennound N, Montemont G, Gibot S et al (2007) Comparative effect of early versus delayed use of norepinephrine in resuscitated endotoxic shock. Crit Care Med 35:1736–1740

    Article  Google Scholar 

  13. Monnet X, Teboul JL (2012) Cardiovascular effects of norepinephrine in septic shock. In: Vincent JL (ed) Annual update in intensive care and emergency medicine. Springer, Heidelberg, pp 65–75

    Google Scholar 

  14. Georger JF, Hamzaoui O, Chaari A et al (2010) Restoring arterial pressure with norepinephrine improves muscle tissue oxygenation assessed by near-infrared spectroscopy in severely hypotensive septic patients. Intensive Care Med 36:1882–1889

    Article  CAS  PubMed  Google Scholar 

  15. De Backer D, Creteur J, Silva E, Vincent JL (2003) Effects of dopamine, norepinephrine and epinephrine on the splanchnic circulation in septic shock: which is the best? Crit Care Med 31:1659–1667

    Article  PubMed  Google Scholar 

  16. Albanes J, Leone M, Garnier E et al (2004) Renal effects of norepinephrine in septic and non septic patients. Chest 126:534–539

    Article  Google Scholar 

  17. Deruddre S, Cheisson G, Mozart JX et al (2007) Renal arterial resistance in septic shock: effects in increasing mean arterial pressure with norepinephrine on the renal resistive index assessed by Doppler ultrasonography. Intensive Care Med 33:1557–1562

    Article  PubMed  Google Scholar 

  18. Thooft A, Favory R, Ribeira Solgado D et al (2011) Effects of changes in arterial pressure on organ perfusion during septic shock. Crit Care 15:R222

    Article  PubMed Central  PubMed  Google Scholar 

  19. Lucinda K, Barrett MA, Singer M et al (2007) Vasopressin: mechanisms of action on the vasculature in health and in septic shock. Crit Care Med 35:33–40

    Article  Google Scholar 

  20. Kaufman JE, Bezzi M, Vischer UM (2003) Desmopressin (DDAVP) induces NO production in human endothelial cells on V2 receptors. J Thromb Haemost 1:821–828

    Article  Google Scholar 

  21. Traber DL (2007) Selective V1 receptor agonists in experimental septic shock. Crit Care 11:P51, abstract

    Article  PubMed Central  Google Scholar 

  22. Rehberg S, Laporte R, Enkhbaatar P et al (2009) Arginine vasopressin increases plasma level of Willebrand factor in sheep. Crit Care 13:A182

    Article  Google Scholar 

  23. Rehberg S, Ermer C, Lange M et al (2010) Role of selective V2 receptor antagonism in septic shock: a randomized, controlled, experimental study. Crit Care 14:R200

    Article  PubMed Central  PubMed  Google Scholar 

  24. Rehberg S, Westphal M, Ertemer C (2012) Vasopressin therapy in septic shock. In: Vincent JL (ed) Annual update in intensive care and emergency medicine. Springer, Heidelberg, pp 76–84

    Google Scholar 

  25. Torgersen C, Luckner G, Schroder DC et al (2011) Concomitant arginine-vasopressin and hydrocortisone therapy in severe septic shock: association with mortality. Intensive Care Med 37:1432–1437

    Article  CAS  PubMed  Google Scholar 

  26. Russel JA, Walley KR, Gordon AC et al; For the VASST investigators (2009) Interaction of vasopressin infusion, corticosteroid treatment and mortality of septic shock. Crit Care Med 37:611–818

    Google Scholar 

  27. O’Brien A, Clapp L, Singer M (2002) Terlipressin for norepinephrine resistant septic shock. Lancet 359:1209–1210

    Article  PubMed  Google Scholar 

  28. Lanzier F (2011) Arginine vasopressin and corticosteroids in septic shock: engaged but not yet married! Intensive Care Med 37:1406–1408

    Article  Google Scholar 

  29. Morelli A, Ermer C, Lange M et al (2007) Continuous terlipressin infusion in patients with septic shock: less may be best, and the earlier the better? Intensive Care Med 38:1669–1670

    Article  Google Scholar 

  30. Dunser MW, Mayr AJ, Ulmer H et al (2003) Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation 107:2313–2319

    Article  PubMed  Google Scholar 

  31. Luckner G, Mayr VD, Jochberger S et al (2007) Comparison of two dose regimens of arginine vasopressin in advanced vasodilatory shock. Crit Care Med 35:2280–2285

    Article  CAS  PubMed  Google Scholar 

  32. Torgersen C, Dunser MW, Wenzel V et al (2010) Comparing two different arginine-vasopressin doses in advanced vasodilatory shock: a randomized controlled, open-label trial. Intensive Care Med 36:57–65

    Article  CAS  PubMed  Google Scholar 

  33. Pasler M, Dietr S, Werdan K (2012) Hypogammaglobulinemia in sepsis. In: Vincent JL (ed) Annual update in intensive care and emergency medicine. Springer, Heidelberg, pp 98–108

    Google Scholar 

  34. Nakado TA, Russe JA, Wellman H et al (2011) Lencyl/cystinyl aminopeptidase gene variants in septic shock. Chest 139:1042–1049

    Article  Google Scholar 

  35. Puskarich MA (2012) Emergency management of severe sepsis and septic shock. Curr Opin Crit Care 18:295–300

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Critical Patient Department, National Institute for the Study and Treatment of Tumors, Milan, Milan, Italy

    Biagio Allaria

Authors
  1. Biagio Allaria
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Biagio Allaria .

Editor information

Editors and Affiliations

  1. Dipartimento di Anestesia, Rianimazione e Terapia del Dolore, Ospedale Maggiore Policlinico Fondazione IRCCS Ca’ Granda, Milano, Italy

    Davide Chiumello

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Allaria, B. (2015). The Role of Noradrenaline, Vasopressin, and Terlipressin in Septic Shock. In: Chiumello, D. (eds) Practical Issues Updates in Anesthesia and Intensive Care. Springer, Cham. https://doi.org/10.1007/978-3-319-18066-3_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-18066-3_4

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-18065-6

  • Online ISBN: 978-3-319-18066-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation